BENEFITS Effortless weight loss Scientifically proven results Improved health Reduced risks for metabolic conditions Well tolerated Easy to use FDA approved SEMAGLUTIDE Semaglutide( known as Ozempic & Wegovy) is a once-weekly injection of GLP-1 agonist for weight loss due to a reduction in appetite, cravings, increased feelings of fullness and improved glucose metabolism
Severe nausea Persistent vomiting Marked fatigue 15.2 Severe Gastrointestinal Effects Profound gastrointestinal symptoms can lead to dehydration and electrolyte imbalance, requiring medical intervention
Carretero Gmez J, Galeano Fernndez TF, Vidal Ros AS, Prez Palacios MR, Garca Garca GM, Garca Carrasco C, et al
Citing limitations in the study, Novo Nordisk, which makes the drugs included in the claims analysis, said in a statement reported by Reuters that it does not believe these data are sufficient to draw conclusions about overall patient adherence and persistence to various GLP-1 medicines, including our treatments. Nonetheless, the problem of lack of patient persistence on GLP-1s under real-world conditions, examined and published by a growing number of sources, isnt going away
Pharmacy cash pricing is roughly $100$150 per month